Remove 2022 Remove Anxiety disorders Remove Manufacturing
article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

Dhar: Is this what inspired you to create the “documentary” for ‘Motivational Deficiency Disorder’ and the April Fool piece in BMJ along with it? In 2022, drug and device makers paid 20 billion Australian dollars to U.S. We investigated social anxiety disorder. What was that about? Moynihan: That’s exactly right.